Introduction: There are ample of psychotropic drugs in the market and their enormous use is seen day by day in psychiatric departments and peripheral institutions. The epidemiological data are limited regarding Adverse drug reaction (ADR) reporting due to these medications and its comparison with intensive monitoring studies in terms of causality, seriousness and preventability. Objectives: To assess the prevalence and different spectrum of adverse drug reactions and to find out the causal relationship, severity and preventability. Material and Methods: This is a cross sectional, hospital based study carried out in Preventability of ADR due to medications were assessed. To predict the association of ADRs with different variables like age, gender and prescribed no of medications, assessment was done by binomial logistic regression method. Results: Out of 289 no of patients reported with suspected ADRs, 168 (58.13%) were male and irrespective of gender maximum ADRs were reported in 20-29 yrs of age group. Total no of suspected ADRs reported were 410. Maximum no (33.56%) of patients were receiving three drugs, followed by 29.41% were on four drugs. Maximum were diagnosed as schizophrenia spectrum of disorders (35.29%) followed by Bipolar affective disorder 37(15.74%). Most common ADR observed was extra pyramidal syndrome (EPS) (20.24%). Frequently encountered drug causing ADRs was Olanzapine (22.43%). Among the ADRs 60.55% were of probable type, 61.09% of mild type in severity and regarding preventability, 87.64% were not preventable. There was no predictable significant association of age, gender and no of medications with suspected ADRs. Conclusion: Our study shows EPS was the commonest ADR detected and Olanzapine was the commonest drug causing ADRs. Majority of ADRs were assessed as probable, severity was mild and not preventable.
Introduction
According to W.H.O, Adverse Drug Reaction is defined as "Any response to a drug which is noxious, unintended and undesirable, and which occurs at doses normally used in human for prophylaxis, diagnosis, or therapy of disease, or for the modification of physiological function" [1] . Psychotropic drugs, also sometimes called as psychoactive drugs, affect the central nervous system and can change in behavior pattern as well as perception. They substancially decrease the intensity of psychiatric symptoms such as delusions, hallucinations and depression and therefore enhance the mental well-being of psychiatric patients, but the diverse range of adverse effects induced by these drugs, tremendously worsens both the physical and mental well being which lead to non adherence to therapy [2] . ADRs in hospitalized psychiatric patients are not only common, but they also have a high rate of preventability [3] [4] . In accordance to one study, 20.4% of reported ADRs over a 3-year period in a state psychiatric hospital were preventable [3] . Their study also found that psychiatric medications were responsible for 48.4% of ADRs. Preventable ADRs accounted for 13% of all ADRs in a psychiatric hospital and that atypical antipsychotics accounted for 37% of all ADRs according to another study [4] . There are reports of transfer of psychiatric patients to a medical hospital due to ADRs [5] . Pharmacovigilance in Psychiatry Department plays a crucial role in detecting ADRs and alerting Physicians to the possibility and circumstances of such events, thereby protecting the user population from the harm caused by medications which are avoidable [6] . In India, Pharmacovigilance activities still in nascent stage and there are limited studies available on the ADR profile of psychotropic drugs [7] . Clinicians' awareness about the adverse effects of psychotropic drugs and their preventability can foster rational and safe use of these sort of medications.
Objectives
This study was undertaken to assess 1. 10.2 % has been assumed as the proportion [8] . Minimum sample size determination procedure for estimating a population proportion was adopted here. The formula used for the purpose is as follows:
Where n = Minimum sample size = value of the standard normal variant for level of significance P = Anticipated population proportion 100( )% = Confidence level d= absolute precession required on either side of the population. In this study following values of the above parameters have been considered keeping view of the frequency of availability of the cases in the study hospital. i) Confidence level = =95% ii) Anticipated population proportion P=10.2% iii) Absolute precision d = 2% point For these values of the input, the minimum sample size required was computed as 880. Assuming 10% follow up loss i.e. 88, the minimum sample size was computed as 968. Our sample size was taken as 1081. Suspected ADRS were collected from patients as per inclusion criteria. Data entry into excel sheet and assessment of causality, severity and preventability was done in Department of Pharmacology. Drug interactions were analysed by using Medscape and Drugs.com drug interaction checker. Causality assesment was done by using WHO-UMC Scale, Preventability assessment by Schumock and Thornton scale [9] & Severity assessment by Hartwig's severity scale [10] . To establish the causality various libraries, databases like Pubmed, Cochrane, Embase and various text books were searched.
Statistical Analysis
Data was entered in Microsoft Excel and was imported to trial version of SPSS v 24. Normality of distribution was estimated by Shapiro-Wilk test and Kolmogorov-Smirnov test. Continuous data was summarized as mean ± standard deviation. Categorical variables were summarized as percentages. All continuous data were converted to binomial variables and binomial logistic regression was estimated to predict the association between the dependent variable (ADRs) vs independent variavles like (age, gender and no of medication) in the form of odd's ratio and confidence interval. P < 0.05 is considered as statistically significant. The results were presented in the form of text, tables, and figures.
Results
Out of the total 1081 patients enrolled in our study, 289 (26.73%) patients reported with Suspected ADRs. Total no of suspected ADRS were 410 and total no of different spectrum of ADRS were 41. Male: Female ratio was 1 Table 5 showed binomial logistic regression analysis to predict the association of patients with suspected ADRs with age group, gender and no of medications. There was statistically significant association between them. (14), Sjs-Ten (7), Mpdr (6) (2) Acute Dystonia (6) Haloperidol (6) Edema / Swelling (51) Olanzapine (45), Quetiapine (2), Amitryptiline (2) Constipation (8) Olanzapine (4), Mirtazapine (1), Clozapine (1), Amisulpiride (1), Aripiprazole (1) Tremor (41) Haloperidol (3), Risperidone (15), Olanzapine (11), Clozapine (4), Chlorpromazine (3), Lithium
Slurring of speech (8) Nitrazepam (2), Haloperidol (3), Lithium (2), Fluvoxamine (1) Lightheadedness (3) Nitazepam (1), Clonazepam (1), Dothiepin (1) Ataxia (6) Valproate (2), Carbamazepine (1), Topiramate (1), Lithium (1) Sialorrohoea (17) Clozapine (13), Risperidone (4) Dyspepsia (7) Fluvoxamine (3), Duloxetine (2) Skin rash (17) Valproate (6), Carbamazepine (4), Lamotrigine (4), Oxcarbamazine (1), Divalproate
Generalized weakness (8) Amitryptiline (3), Escitalopram (2), Topiramate (2), Levateracetam (1) Nausea/Vomit (13) Valproate (5), Flavoxamine (2), Sertraline(2), Divalproate (2), Aripiprazole (1), Topiramate (1) Akathisia (5) Haloperidol (2), Olanzapine (1), Risperidone (1), Thioridazine (1) MPDR (6) Phenytoin (6) Agitation (5) Risperidone (2), Amisulpiride (1), Fluoxetine(1) , Loxapine (1) SJS-TEN (7) Phenytoin (3), Carbamazepine (2), Levateracetam (2) Decreased libido (8) Amisulpiride (2), Risperodone(2), Fluoxetine (1), Thioridazine (1), Chloropromazine (1), Sertraline (1) Impaired Glucose Tolerance (4) Olanzepine (2), Quetiapine (2) Lethargy (8) Clonazepam (2), Fluvoxamine (4) Gidiness (4) Risperidone (1), Sertraline (1), Loxapine (2) Hyperprolactinemia (3) Amisulpiride (3) Insomnia (5) Sertraline (2), Amisulpiride (2), Fluvoxamine (1) Headache (4) Sertraline(1), Fluoxetine(1),Fluvoxamine(1) Amenorrhoea (4) Haloperidol (2), Olanzepine (2) Postural hypotension (2) Risperidone (2) Nephropathy (3) Lithium (3) Urinary incontinence (5) Olanzepine (2), Quetiapine (2),Thioridazine(1) Sedation (23) Lorazepam (12), Nitrazepam (5), Amitryptiline (1), Quetiapine (2), Dothiepin (1), Clonazepam (1),Thioridazine (1) Dry mouth (5) Olanzepine (1) 
Weight gain (13) Olanzapine (7), Quetiapine (2), Amitryptiline (1),Mirtazapine (1) Agranulocytosis (2) Clozapine (2) 
Discussions
Incidence of ADRs found in our study (26.73%) was similar to a study conducted by Shah et al, that had found 32.80% of patients in psychiatric in-patient setting, reported ADRs [11] . Incidence of ADRs found in our study was in contrast to study in two psychiatric hospitals in Germany where it was 60.7% whereas another study by Sridhar SB et al it was 10.2% in OPD patients. [12, 8] . A study conducted in Brazil in 2001 showed that 219 suspected ADRs of psychoactive medications and antidepressants were the commonest groups responsible for the ADRs [13] . In our study antipsychotics were responsible for most of the ADRs. There were more male patients who developed ADRs on administration of psychotropic agents that is similar to the findings of previous studies [14, 15] . Our finding contrasts with few studies where more female developed ADRs than male [16, 17] . The most common age group in which these ADRs were observed was in the 20-29 years (30.54%). Although ADRs are known to be frequently occurring in the geriatric age group, only 4.36% patients from the age group > 60 years attending our Mental health institute showed ADRs. The medication classes most frequently associated with ADRs in our study were antipsychotics (60.97%) (mostly atypical or second generation antipsychotics) followed by antidepressants (14.39%) and mood stabilizers 12.68% (including the antiepileptics used for mood stabilization). According to study by Thomas et al, antiepileptics and second-generation (atypical) antipsychotics were the common causes of ADRs [3] . Segregation was done on the basis of disease diagnosed [ Figure-2 ] and the distribution of data according to suspected ADRs is shown in Table 1 . Drugs use pattern in prescriptions are tabulated in Table 3 . Extrapyramidal symptoms, edema, swelling and weight gain were found to be the most common adverse effect induced by psychotropic agents according to our study [ Table 1 , Table 3 ]. The second generation anti-psychotics Olanzapine, Quetiapine and among anti depressants Amitryptiline are known to cause weight gain. A direct link between cytokines and increase in body mass index (BMI) following Olanzapine therapy has also been described [18] . Olanzapine also impairs glucose regulation and causes dyslipidemia which leads to increase in body fat [19, 20] . Increase in serum leptin level was also attributed as a cause of weight gain in patients treated with second generation antipsychotics [21] . Second generation anti-psychotics Olanzapine and Clozapine have low propensity of extra pyramidal side effects compared to conventional antipsychotics like Haloperidol. However they also induce tremors, akasthisia and tardive dyskinesia [22] . According to our study few cases of tremors are reported due to Olanzapine, Clozapine, Risperidone as shown in Table-3. Regarding causality assessment, our study had no "certain" cases on WHO causality assessment scale since the suspected ADRs were mostly of mild to moderate severity [Table-4] and hence did not require withdrawal of therapy as well as patients were on multiple medications which is in contrast to another study by Sridhar et al which mentioned 14.3% were of certain type [8] . In our study, in cases where dechallenge was done, rechallenge was not attempted with the offending drug while in the Brazilian study, 24 cases were found to be "definite" after rechallenge was attempted [13] . Regarding severity assessment, mild and moderate type were maximum in our study which was similar to study by Sridhar et al [8] and Afkat A et al [23] . None of these studies found suspected ADRs to be severe whereas in our study 3.27% ADRs were found to be severe which is a matter of concern. Our study had 9 (3.27%) cases of life threatening "severe" category ADRs [Table- 4] , while in the Brazilian study 12 cases were found to be life threatening "severe" category ADRs [13] . Regarding preventability assessment, our study had 50 (12.36%) cases of "preventable" ADRs [Table-4 ] while according to another study, 12 ADRs were found to be "preventable" [24] . In our study maximum ADRs were not preventable [360 (87.64%)]. This finding corresponds with that of Nithya et al. reported that all the ADRs to psychotropic drugs were not preventable [25] ; while In another study by Lahon et al. mentioned a good number of the ADRs were probably preventable. [26] Age, gender, number of drugs received or polypharmacy and race are the predisposing factors of ADRs [27] According to our study there was no significant association of suspected ADRs with different variables like age group, gender and no of medication [Table- 5] which is similar to studies by Sridhar SB et al [gender (P = 0.06), age (P = 0.36), prescribed number of medications ( P = 0.51)] [8] and by Afkat A et al [age (p=0.8) or sex (p=0.6)] [23] . Another study conducted by Kasper et al. identified that age and male gender as the predictors of tardive dyskinesia in patients with schizophrenia. [28] Limitations of our study As this was a cross sectional study and was done in 2 days per week in OPD and 1day per week in IPD (male & female in alternate week), it might have possible that we had missed a lots of cases which might have a great impact on final results. We had not taken diet and few other confounding factors into account which might have influenced the occurence of ADRs. Apart from routine haematological and biochemical reports, we could not generally order tests like ECG screening of patients, Therapeutic Drug Monitoring of psychotropic drugs (except Lithium in selected cases). One of the important aspect is that we coul dnot assess the adherance of the patients to psychotropic medications.
Conclusion
The prevalence of ADRs in our study population was high (26.73%). Most of them (61.09%) were mild in nature followed by 35.63% of moderate severity and 3.27% severe ADRs which led to discontinue the treatment. The present study adds to the existing data on the prevalence and severity of ADRs following psychotropic medications from the other centers and create awareness among our health care professionals about the importance of active surveillance studies. The knowledge about the possible ADRs and their severity will help the health care professionals to be vigilant about preventing, early detection, treating and alleviating the adverse health effects due to ADRs, thereby reducing the risk of morbidity and mortality caused by ADRs. Hence it may improve the quality of care, curtailing the treatment cost and augmentation of medication adherence pattern among patients.
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